| Association of dementia with mortality among adults with Down syndrome older than 35 years R Hithersay, CM Startin, S Hamburg, KY Mok, J Hardy, EMC Fisher, ... JAMA neurology 76 (2), 152-160, 2019 | 139 | 2019 |
| Health comorbidities and cognitive abilities across the lifespan in Down syndrome CM Startin, H D’Souza, G Ball, S Hamburg, R Hithersay, KMO Hughes, ... Journal of neurodevelopmental disorders 12, 1-13, 2020 | 125 | 2020 |
| Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain I Alić, PA Goh, A Murray, E Portelius, E Gkanatsiou, G Gough, KY Mok, ... Molecular psychiatry 26 (10), 5766-5788, 2021 | 93 | 2021 |
| Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome CM Startin, S Hamburg, R Hithersay, T Al-Janabi, KY Mok, J Hardy, ... Alzheimer's & Dementia 15 (2), 245-257, 2019 | 80 | 2019 |
| Cognitive decline and dementia in Down syndrome R Hithersay, S Hamburg, B Knight, A Strydom Current opinion in psychiatry 30 (2), 102-107, 2017 | 79 | 2017 |
| Aging related cognitive changes associated with Alzheimer's disease in Down syndrome NC Firth, CM Startin, R Hithersay, S Hamburg, PA Wijeratne, KY Mok, ... Annals of Clinical and Translational Neurology 5 (6), 741-751, 2018 | 78 | 2018 |
| Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease CM Startin, NJ Ashton, S Hamburg, R Hithersay, FK Wiseman, KY Mok, ... Alzheimer's research & therapy 11, 1-12, 2019 | 69 | 2019 |
| The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome CM Startin, S Hamburg, R Hithersay, A Davies, E Rodger, N Aggarwal, ... Wellcome open research 1, 2016 | 66 | 2016 |
| Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review S Hamburg, B Lowe, CM Startin, C Padilla, A Coppus, W Silverman, ... Journal of neurodevelopmental disorders 11, 1-16, 2019 | 47 | 2019 |
| Developing an informant questionnaire for cognitive abilities in Down syndrome: The Cognitive Scale for Down Syndrome (CS-DS) CM Startin, E Rodger, L Fodor-Wynne, S Hamburg, A Strydom PLoS One 11 (5), e0154596, 2016 | 39 | 2016 |
| Call to join the decentralized science movement S Hamburg Nature 600 (7888), 221-221, 2021 | 24 | 2021 |
| Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome R Hithersay, RA Baksh, CM Startin, P Wijeratne, S Hamburg, B Carter, ... Alzheimer's & Dementia 17 (4), 595-604, 2021 | 23 | 2021 |
| The association between physical activity and CAMDEX-DS changes prior to the onset of Alzheimer’s disease in Down Syndrome SE Pape, RA Baksh, C Startin, S Hamburg, R Hithersay, A Strydom Journal of Clinical Medicine 10 (9), 1882, 2021 | 22 | 2021 |
| Validating the Cognitive Scale for Down Syndrome (CS-DS) to detect longitudinal cognitive decline in adults with Down syndrome CM Startin, B Lowe, S Hamburg, R Hithersay, A Strydom, ... Frontiers in Psychiatry 10, 158, 2019 | 21 | 2019 |
| Dynamic causal modeling of the relationship between cognition and theta–alpha oscillations in adults with Down syndrome S Hamburg, R Rosch, CM Startin, KJ Friston, A Strydom Cerebral Cortex 29 (5), 2279-2290, 2019 | 18 | 2019 |
| Differential associations of apolipoprotein E ε4 genotype with attentional abilities across the life span of individuals with Down syndrome H D’Souza, L Mason, KY Mok, CM Startin, S Hamburg, R Hithersay, ... JAMA network open 3 (9), e2018221-e2018221, 2020 | 11 | 2020 |
| Comparison of receptive verbal abilities assessed using the KBIT-2 and BPVS3 in adults with Down syndrome CM Startin, S Hamburg, A Strydom, LonDownS Consortium Frontiers in psychology 9, 2730, 2019 | 11 | 2019 |
| Comparison of resting-state EEG between adults with Down syndrome and typically developing controls S Hamburg, D Bush, A Strydom, CM Startin Journal of Neurodevelopmental Disorders 13, 1-11, 2021 | 10 | 2021 |
| Accelerated biological aging in people with Down syndrome with full and segmental trisomy 21 begins in childhood as revealed by immunoglobulin G glycosylation A Cindric, F Vuckovic, D Koschut, V Borelli, J Juric, M Pucic-Bakovic, ... | 5 | 2021 |
| Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain I Alić, PA Goh, A Murray, E Portelius, E Gkanatsiou, G Gough, KY Mok, ... Molecular Psychiatry 26 (10), 5789, 2021 | 3 | 2021 |
